The epigenetic gene silencing of SOCS3 due to promoter methylation is observed in many malignancies, including head-neck cancer [22], cervical cancer [23], pancreatic cancer [24] and hepatocellular cancer [24]. Here, SOCS3 is linked to familial pancreatic carcinoma.